EP3030251
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
:
EP einkaleyfi: Þýðing ekki lögð inn:
8.8.2014:
24.10.2018:
14752766.7
:
7.8.2034
:
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
8.8.2014
24.10.2018
:
Onyx Therapeutics, Inc.:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
:
TUCH, Brian:
Brisbane, CA, US
:
DEGENHARDT, Jeremiah:
San Mateo, CA, US
:
LOEHR, Andrea:
San Francisco, CA, US
:
KWEI, Kevin:
Mountain View, CA, US
:
KIRK, Christopher, J.:
San Francisco, CA, US
:
201361863809 P:
8.8.2013:
US
:
201361875954 P:
10.9.2013:
US
:
201462005904 P:
30.5.2014:
US
:
US2014050333:
8.8.2014
:
A61K 38/05, A61K 38/07, A61K 31/145, A61P 35/02, C12Q 1/68, G01N 33/574